BioNexus Gene Lab BGLC
NASDAQ BGLC
$1.27 -0.03 (-2.31%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioNexus Gene Lab (BGLC) EV to EBITDA (2021 - 2022)

Updated

BioNexus Gene Lab's EV to EBITDA came in at 1497.59 for Q3 2022, up 632.9% from 204.33 a year earlier and up 326.9% from the prior quarter.

Analysis

BioNexus Gene Lab (BGLC) EV to EBITDA (2021 - 2022) Analysis & Trends

Over the trailing twelve months to Sep 30, 2022, BioNexus Gene Lab reported EV to EBITDA of 1454.07, up 636.4% year-over-year; for FY2021, it came in at 316.06.

  • Business Quant data shows BGLC's EV to EBITDA at 350.84 (Q2 2022), 341.72 (Q1 2022) and 316.07 (Q4 2021) in the three quarters before Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 W.W. Grainger 59.11 Bn 57.09 Bn 1.98 Bn
2 Fastenal 57.94 Bn 56.86 Bn 1.06 Bn
3 Ferguson Enterprises 44.13 Bn 41.35 Bn 2.32 Bn
4 Sunbelt Rentals Holdings 30.69 Bn 30.57 Bn 1.25 Bn
5 Reliance 20.00 Bn 19.04 Bn 1.30 Bn
6 Wesco International 17.78 Bn 15.09 Bn 1.46 Bn
7 Applied Industrial Technologies 12.42 Bn 12.29 Bn 411.22 Mn
8 Watsco 11.14 Bn 9.30 Bn 578.93 Mn
9 Avantor 10.34 Bn 9.14 Bn 537.00 Mn
10 BioNexus Gene Lab 2.41 Mn -4.96 Mn 12,982.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 1,497.59
Jun 30, 2022 350.84
Mar 31, 2022 341.72
Dec 31, 2021 316.07
Sep 30, 2021 204.33
Jun 30, 2021 234.61
Mar 31, 2021 563.62
API Access

BioNexus Gene Lab EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BGLC&period=max&api_key=YOUR_API_KEY